| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |